Skip to main content
UniHealth

Doctor search

Sandra A Tsai, MD

Internal Medicine · Stanford

NPI 1083717359

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
13
2 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

13 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tsai’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

13 of 13 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A65925 · Current

Licensed to practise in California · since 1998 · expires 2027-11-30 · University of Texas Southwestern Medical School at Dallas.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$28,901

Medicare paid this office $28,901 for 242 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)83$7,904$75
Return visit (30+ min)59$4,918$58
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit55$3,355$61
Long return visit (40+ min)25$2,720$91
Long return visit (40+ min)34$2,682$61
See all 10 services
Every Original Medicare service billed
Return visit (30+ min)83$7,904$75
Return visit (30+ min)59$4,918$58
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit55$3,355$61
Long return visit (40+ min)25$2,720$91
Long return visit (40+ min)34$2,682$61
Short return visit (20+ min)22$1,421$57
Short return visit (20+ min)17$856$48
Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report28$364$13
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's19$300$15
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's11$195$15

Who their Medicare patients are

242 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Women 67% · Also on Medicaid 20% · Health risk score 1.07. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.

Conditions among them: High blood pressure 71% · Coronary heart disease 28% · Diabetes 26% · Cancer 19% · Chronic kidney disease 17% · Depression 15% · Atrial fibrillation 14% · Stroke 11% · Heart failure 10% · COPD 6% · Dementia 5%.

The office billed $211,290, Medicare allowed $43,583 and paid $28,901; for 470 services of 16 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024242470751.07$211,290$28,901
2023239406741.02$180,853$25,587
2022182366750.96$183,722$23,163
2021180393741.00$189,789$25,487
2020156313741.05$96,519$18,405
2019167338731.07$48,460$24,958
2018162352721.06$55,450$26,373
2017150299721.08$65,421$21,966
2016159323721.08$75,132$22,811
2015171322721.35$69,805$21,685
2014163343721.15$67,856$20,677
2013172390721.16$77,146$23,316

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Original Medicare services billed in 2023
Return visit (30+ min)121$9,964$59
Long return visit (40+ min)45$5,303$88
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit61$3,815$63
Short return visit (20+ min)35$1,876$48
New patient visit (60+ min)12$1,740$145
Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report32$526$16

2022: 5 services

Original Medicare services billed in 2022
Return visit (30+ min)86$8,145$61
Long return visit (40+ min)50$5,170$72
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit43$2,763$64
Short return visit (20+ min)47$2,522$48
New patient visit (60+ min)15$2,179$145

2021: 7 services

Original Medicare services billed in 2021
Return visit (30+ min)91$8,299$61
Long return visit (40+ min)57$5,847$68
Short return visit (20+ min)46$2,832$51
New patient visit (60+ min)16$2,143$134
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit33$1,854$56
Telephone medical discussion with physician, 21-30 minutes15$1,271$71
Telephone medical discussion with physician, 11-20 minutes14$955$56

2020: 7 services

Original Medicare services billed in 2020
Return visit (30+ min)83$8,216$66
Short return visit (20+ min)34$1,577$40
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit11$1,576$143
Long return visit (40+ min)22$1,456$63
Telephone medical discussion with physician, 11-20 minutes29$1,402$39
Telephone medical discussion with physician, 21-30 minutes17$1,323$66
Return visit (30+ min)19$1,082$52

2019: 5 services

Original Medicare services billed in 2019
Return visit (30+ min)113$12,703$63
Long return visit (40+ min)35$5,660$93
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit22$3,105$141
New patient visit (60+ min)11$1,675$152
Short return visit (20+ min)29$1,339$41

2018: 6 services

Original Medicare services billed in 2018
Return visit (30+ min)59$5,722$66
Return visit (30+ min)55$5,156$59
Long return visit (40+ min)34$4,339$94
Long return visit (40+ min)28$3,836$80
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit15$2,106$140
Short return visit (20+ min)27$1,290$40

2017: 6 services

Original Medicare services billed in 2017
Return visit (30+ min)64$6,281$60
Long return visit (40+ min)35$5,255$89
Return visit (30+ min)25$2,990$60
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit21$2,909$139
Long return visit (40+ min)15$1,685$94
Short return visit (20+ min)18$776$39

2016: 6 services

Original Medicare services billed in 2016
Return visit (30+ min)66$7,279$60
Return visit (30+ min)38$3,835$63
Long return visit (40+ min)23$2,775$82
New patient visit (60+ min)18$2,319$129
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit14$1,927$138
Short return visit (20+ min)32$1,516$39

2015: 4 services

Original Medicare services billed in 2015
Return visit (30+ min)113$12,277$62
Short return visit (20+ min)49$2,904$42
New patient visit (60+ min)13$1,832$141
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit13$1,801$139

2014: 3 services

Original Medicare services billed in 2014
Return visit (30+ min)98$11,472$62
Short return visit (20+ min)75$4,140$39
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit12$1,617$135

2013: 3 services

Original Medicare services billed in 2013
Return visit (30+ min)115$14,281$61
Short return visit (20+ min)68$3,859$40
New patient visit (45+ min)11$1,037$94

Drugs they prescribed that Part D paid

$166,058

Pharmacies billed $166,058 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 1% of their Part D prescriptions (24 of 1,774) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.

1,542 generic and 211 brand-name prescriptions · $166,058 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Eliquis26$33,201$1,277
Repatha Sureclick30$23,900$797
Atrovent Hfa13$5,968$459
Belsomra12$5,072$423
Nexletol11$4,378$398
See all 41 drugs
Every Part D drug this clinician prescribed
Eliquis26$33,201$1,277
Repatha Sureclick30$23,900$797
Atrovent Hfa13$5,968$459
Belsomra12$5,072$423
Nexletol11$4,378$398
Ezetimibe64$2,141$33
Rosuvastatin126$1,858$15
Dexlansoprazole Dr11$1,650$150
Atorvastatin158$1,584$10
Olmesartan-Hydrochlorothiazide17$1,088$64
Amlodipine Besylate128$1,050$8
Ultra-Fine Mini Pen Needle14$839$60
Metoprolol30$813$27
Levothyroxine62$740$12
Eplerenone12$724$60
Azelastine16$702$44
Losartan93$571$6
Olmesartan Medoxomil22$450$20
Lisinopril53$438$8
Losartan-Hydrochlorothiazide14$437$31
Doxazosin Mesylate25$434$17
Pregabalin17$369$22
Pantoprazole24$359$15
Alendronate31$324$10
Albuterol Sulfate Hfa14$305$22
Hydrochlorothiazide61$259$4
Metformin48$213$4
Pravastatin17$196$12
Chlorthalidone16$195$12
Atenolol15$182$12
Carvedilol19$181$10
Oxycodone-Acetaminophen11$173$16
Tamsulosin14$154$11
Trazodone43$139$3
Gabapentin20$125$6
Simvastatin18$105$6
Spironolactone21$104$5
Furosemide27$101$4
Omeprazole16$90$6
Sertraline13$50$4
Clonidine12$40$3

Year by year

Part D prescribing by year
20241,7742001% (24)12%$166,058
20231,7701921% (13)14%$187,575
20221,8821991% (15)10%$141,521
20211,8272091% (19)11%$145,389
20201,706162NoneNone$130,204
20191,932193NoneNone$156,204
20181,7522151% (20)14%$114,754
20171,5231762% (24)12%$100,392
20161,5681683% (40)15%$92,698
20151,3831384% (55)None$84,330
20141,2631143% (40)16%$72,515
20131,2411523% (41)16%$63,528

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 44 drugs

Part D drugs prescribed in 2023
Eliquis34$36,571$1,076
Repatha Sureclick46$35,777$778
Ozempic11$13,085$1,190
Myrbetriq11$5,293$481
Rosuvastatin120$2,914$24
Atorvastatin150$2,774$18
Ezetimibe47$1,615$34
Doxazosin Mesylate23$1,496$65
Ventolin Hfa15$1,423$95
Losartan99$1,302$13
Amlodipine Besylate129$1,263$10
Olmesartan-Hydrochlorothiazide24$1,185$49
Telmisartan16$1,054$66
Levothyroxine55$982$18
Metoprolol27$803$30
Sure Comfort Pen Needle12$651$54
Gabapentin17$595$35
Losartan-Hydrochlorothiazide11$561$51
Metformin50$560$11
Potassium Chloride17$553$33
Olmesartan Medoxomil19$553$29
Lisinopril50$549$11
Alendronate26$535$21
Simvastatin21$483$23
Hydrochlorothiazide54$477$9
Trazodone31$373$12
Carvedilol21$351$17
Chlorthalidone29$329$11
Clopidogrel13$329$25
Spironolactone31$296$10
Famotidine11$292$27
Zolpidem15$266$18
Oxycodone-Acetaminophen12$214$18
Pantoprazole24$193$8
Nitroglycerin11$192$17
Fluticasone Propionate12$178$15
Atenolol12$178$15
Furosemide26$173$7
Metoprolol13$168$13
Clonidine17$166$10
Metformin Hcl Er11$164$15
Omeprazole11$160$15
Pregabalin15$157$10
Tamsulosin12$139$12

2022: 47 drugs

Part D drugs prescribed in 2022
Eliquis21$29,279$1,394
Repatha Sureclick21$12,528$597
Xarelto13$11,613$893
Nexletol17$8,683$511
Rosuvastatin100$3,339$33
Ezetimibe33$2,023$61
Atorvastatin168$1,753$10
Doxazosin Mesylate38$1,584$42
Comfort Ez Pen Needle15$1,348$90
Albuterol Sulfate Hfa23$1,186$52
Levothyroxine49$1,132$23
Losartan114$1,025$9
Amlodipine Besylate155$932$6
Valsartan11$915$83
Clopidogrel24$840$35
Metoprolol28$800$29
Olmesartan-Hydrochlorothiazide13$768$59
Carvedilol43$725$17
Lisinopril59$691$12
Olmesartan Medoxomil16$634$40
Hydrochlorothiazide79$590$7
Potassium Chloride14$531$38
Chlorthalidone37$504$14
Fluticasone Propionate22$393$18
Simvastatin26$393$15
Alendronate23$393$17
Pregabalin16$381$24
Sertraline24$378$16
Pantoprazole25$354$14
Metformin36$345$10
Gabapentin21$320$15
Trazodone17$296$17
Isosorbide Mononitrate Er12$267$22
Spironolactone29$236$8
Metformin Hcl Er22$223$10
Topiramate11$217$20
Tamsulosin20$213$11
Pramipexole Dihydrochloride11$195$18
Omeprazole16$173$11
Oxycodone-Acetaminophen14$171$12
Furosemide24$165$7
Atenolol17$153$9
Mirtazapine14$139$10
Zolpidem15$118$8
Famotidine13$107$8
Triamcinolone Acetonide17$71$4
Clonidine12$57$5

2021: 42 drugs

Part D drugs prescribed in 2021
Eliquis11$16,126$1,466
Januvia13$11,876$914
Repatha Sureclick21$11,651$555
Advair Diskus11$6,644$604
Myrbetriq12$5,294$441
Nexletol11$3,717$338
Rosuvastatin72$3,599$50
Atorvastatin164$2,081$13
Ezetimibe29$1,921$66
Losartan121$1,719$14
Doxazosin Mesylate32$1,470$46
Ventolin Hfa12$1,399$117
Valsartan11$1,376$125
Levothyroxine52$1,125$22
Comfort Ez Pen Needle11$988$90
Amlodipine Besylate133$855$6
Hydrochlorothiazide94$799$8
Olmesartan Medoxomil18$718$40
Alendronate36$664$18
Metoprolol32$613$19
Azelastine13$501$39
Albuterol Sulfate Hfa11$469$43
Pantoprazole26$467$18
Metformin27$407$15
Lisinopril47$404$9
Fluticasone Propionate23$383$17
Chlorthalidone18$373$21
Metformin Hcl Er15$328$22
Gabapentin29$313$11
Sertraline13$269$21
Simvastatin41$247$6
Omeprazole17$235$14
Tamsulosin20$234$12
Pramipexole Dihydrochloride11$231$21
Carvedilol17$228$13
Spironolactone36$226$6
Furosemide28$173$6
Atenolol20$166$8
Trazodone20$156$8
Clopidogrel15$155$10
Fluoxetine15$99$7
Clonidine17$67$4

2020: 41 drugs

Part D drugs prescribed in 2020
Eliquis16$20,361$1,273
Repatha Sureclick17$13,498$794
Xarelto16$13,118$820
Myrbetriq12$5,012$418
Advair Diskus14$4,598$328
Rosuvastatin55$3,193$58
Atorvastatin151$2,023$13
Ventolin Hfa19$1,911$101
Losartan115$1,490$13
Doxazosin Mesylate20$1,485$74
Levothyroxine44$1,165$26
Ezetimibe26$1,110$43
Propranolol15$880$59
Metoprolol33$811$25
Amlodipine Besylate118$724$6
Potassium Chloride12$537$45
Alendronate36$533$15
Hydrochlorothiazide76$512$7
Quinapril15$485$32
Carvedilol46$420$9
Lisinopril60$411$7
Azelastine11$409$37
Duloxetine12$408$34
Fluticasone Propionate26$406$16
Diclofenac12$314$26
Gabapentin27$307$11
Simvastatin51$299$6
Metformin37$286$8
Sertraline21$278$13
Pantoprazole32$260$8
Metformin Hcl Er18$218$12
Triamcinolone Acetonide15$216$14
Olmesartan Medoxomil16$200$13
Spironolactone27$197$7
Clonidine21$153$7
Clopidogrel12$149$12
Atenolol12$124$10
Trazodone18$107$6
Furosemide24$106$4
Metoprolol13$73$6
Omeprazole12$44$4

2019: 42 drugs

Part D drugs prescribed in 2019
Eliquis14$15,686$1,120
Xarelto18$13,870$771
Janumet Xr13$7,737$595
Advair Diskus20$7,070$353
Flovent Hfa13$3,300$254
Rosuvastatin85$3,249$38
Atorvastatin146$2,609$18
Clonidine28$2,119$76
Losartan142$1,655$12
Metoprolol34$1,600$47
Doxazosin Mesylate22$1,478$67
Potassium Chloride20$1,339$67
Ventolin Hfa13$1,334$103
Amlodipine Besylate135$1,084$8
Ezetimibe31$1,047$34
Levothyroxine43$1,017$24
Hydrochlorothiazide101$890$9
Voltaren15$825$55
Azelastine13$793$61
Valsartan11$731$66
Lisinopril69$666$10
Duloxetine17$492$29
Olmesartan Medoxomil16$470$29
Carvedilol50$440$9
Alendronate32$424$13
Simvastatin49$410$8
Esomeprazole Magnesium17$400$24
Metformin36$381$11
Omeprazole26$355$14
Tamsulosin18$332$18
Pantoprazole23$326$14
Gabapentin25$312$12
Pravastatin14$307$22
Sertraline17$229$13
Triamcinolone Acetonide22$204$9
Spironolactone20$195$10
Fluticasone Propionate17$187$11
Clonidine31$186$6
Atenolol17$148$9
Nitroglycerin12$138$12
Trazodone22$100$5
Cyclobenzaprine14$73$5

2018: 42 drugs

Part D drugs prescribed in 2018
Xarelto24$16,142$673
Lyrica13$8,687$668
Flovent Hfa14$3,453$247
Potassium Chloride21$2,586$123
Atorvastatin125$2,283$18
Ezetimibe27$2,232$83
Rosuvastatin54$2,169$40
Ventolin Hfa15$1,633$109
Valsartan20$1,381$69
Metoprolol45$1,296$29
Azelastine19$1,157$61
Levothyroxine33$1,014$31
Losartan89$913$10
Doxazosin Mesylate24$872$36
Amlodipine Besylate121$759$6
Hydrochlorothiazide130$704$5
Lisinopril72$657$9
Propranolol14$631$45
Gabapentin32$543$17
Oxycodone-Acetaminophen12$512$43
Metformin50$447$9
Nifedipine Er18$420$23
Tamsulosin13$393$30
Pravastatin16$372$23
Simvastatin52$327$6
Alendronate30$287$10
Fluticasone Propionate16$267$17
Carvedilol17$205$12
Warfarin11$196$18
Ranitidine12$194$16
Fluoxetine12$188$16
Spironolactone17$179$11
Pantoprazole17$164$10
Cyclobenzaprine14$138$10
Atenolol16$128$8
Omeprazole17$127$7
Lisinopril-Hydrochlorothiazide13$122$9
Zolpidem13$115$9
Trazodone22$107$5
Furosemide25$83$3
Triamcinolone Acetonide12$66$6
Clonidine11$50$5

2017: 39 drugs

Part D drugs prescribed in 2017
Xarelto17$12,882$758
Lyrica13$6,221$479
Metformin Hcl Er12$5,490$458
Lantus12$3,067$256
Rosuvastatin38$2,469$65
Atorvastatin116$2,170$19
Ezetimibe12$1,253$104
Chlorthalidone23$868$38
Amlodipine Besylate92$770$8
Metoprolol26$738$28
Propranolol17$720$42
Valsartan20$685$34
Losartan82$675$8
Doxazosin Mesylate15$561$37
Levothyroxine16$549$34
Oxycodone-Acetaminophen15$499$33
Metformin41$414$10
Gabapentin30$401$13
Pravastatin13$381$29
Potassium Chloride14$379$27
Lisinopril54$342$6
Warfarin11$313$28
Alendronate43$311$7
Simvastatin52$306$6
Hydrochlorothiazide53$293$6
Tamsulosin15$285$19
Fluticasone Propionate17$281$17
Ranitidine12$218$18
Spironolactone20$205$10
Carvedilol29$193$7
Sertraline19$158$8
Clonidine25$137$5
Cyclobenzaprine12$107$9
Atenolol19$105$6
Zolpidem16$95$6
Omeprazole12$92$8
Trazodone15$80$5
Pantoprazole12$62$5
Clonazepam12$53$4

2016: 45 drugs

Part D drugs prescribed in 2016
Crestor23$11,205$487
Bystolic20$2,093$105
Candesartan Cilexetil12$1,702$142
Atorvastatin98$1,672$17
Duloxetine16$1,500$94
Lidocaine12$1,470$123
Metoprolol37$1,416$38
Ventolin Hfa17$1,168$69
Valsartan26$1,053$40
Chlorthalidone33$924$28
Propranolol24$916$38
Pravastatin34$840$25
Gabapentin27$746$28
Doxazosin Mesylate23$709$31
Levothyroxine26$623$24
Losartan64$546$9
Oxycodone-Acetaminophen17$481$28
Simvastatin73$464$6
Amlodipine Besylate69$453$7
Lisinopril60$446$7
Tamsulosin21$396$19
Hydrochlorothiazide61$379$6
Potassium Chloride11$291$26
Spironolactone17$291$17
Metformin46$277$6
Alendronate33$261$8
Fluticasone Propionate21$260$12
Finasteride18$224$12
Sertraline22$212$10
Omeprazole26$201$8
Glimepiride13$201$15
Carvedilol28$200$7
Meclizine12$194$16
Pioglitazone15$190$13
Metoprolol21$165$8
Zolpidem19$159$8
Donepezil15$121$8
Triamterene-Hydrochlorothiazid12$117$10
Tramadol16$95$6
Atenolol15$89$6
Clonazepam12$79$7
Citalopram Hbr13$76$6
Trazodone13$65$5
Clonidine11$58$5
Furosemide15$56$4

2015: 36 drugs

Part D drugs prescribed in 2015
Crestor24$11,240$468
Lantus11$2,841$258
Lidocaine13$2,535$195
Valsartan24$2,215$92
Atorvastatin55$1,417$26
Metoprolol19$984$52
Clopidogrel22$979$44
Pravastatin41$875$21
Hydrocodone-Acetaminophen18$855$47
Propranolol34$811$24
Levothyroxine17$638$38
Doxazosin Mesylate19$630$33
Gabapentin20$578$29
Lisinopril64$532$8
Fluticasone Propionate46$506$11
Tamsulosin21$490$23
Losartan45$487$11
Simvastatin59$409$7
Flecainide Acetate14$400$29
Omeprazole27$320$12
Amlodipine Besylate53$295$6
Alendronate26$285$11
Zolpidem33$274$8
Metformin43$261$6
Finasteride22$239$11
Hydrochlorothiazide32$238$7
Sertraline25$207$8
Spironolactone24$194$8
Pioglitazone15$194$13
Glimepiride15$193$13
Carvedilol33$188$6
Furosemide13$111$9
Metoprolol14$98$7
Clonazepam14$95$7
Donepezil14$90$6
Tramadol16$87$5

2014: 34 drugs

Part D drugs prescribed in 2014
Crestor17$6,916$407
Diovan26$6,128$236
Duloxetine12$2,906$242
Metoprolol25$1,516$61
Lidocaine13$1,254$96
Atorvastatin44$1,216$28
Clopidogrel18$1,115$62
Pravastatin45$1,103$25
Isosorbide Dinitrate11$1,036$94
Doxazosin Mesylate14$956$68
Hydrocodone-Acetaminophen17$796$47
Losartan44$763$17
Simvastatin65$741$11
Propranolol28$682$24
Donepezil15$658$44
Flecainide Acetate16$629$39
Fluticasone Propionate26$591$23
Lisinopril57$588$10
Levothyroxine16$474$30
Metformin40$402$10
Tamsulosin23$397$17
Omeprazole35$387$11
Carvedilol35$292$8
Amlodipine Besylate35$290$8
Alendronate25$259$10
Zolpidem28$252$9
Allopurinol19$243$13
Pioglitazone12$230$19
Trazodone23$200$9
Finasteride21$191$9
Hydrochlorothiazide40$152$4
Metoprolol16$126$8
Furosemide18$116$6
Triamcinolone Acetonide14$88$6

2013: 32 drugs

Part D drugs prescribed in 2013
Crestor25$6,592$264
Donepezil16$1,755$110
Metoprolol22$1,751$80
Atorvastatin33$1,195$36
Losartan81$1,138$14
Simvastatin98$1,074$11
Fluticasone Propionate31$921$30
Propranolol34$791$23
Gabapentin21$770$37
Felodipine Er15$763$51
Lisinopril73$701$10
Doxazosin Mesylate19$546$29
Hydrochlorothiazide56$421$8
Pravastatin20$407$20
Omeprazole32$392$12
Tamsulosin17$353$21
Amlodipine Besylate33$344$10
Hydrocodone-Acetaminophen15$338$23
Levothyroxine21$301$14
Metformin24$274$11
Carvedilol32$273$9
Alendronate15$229$15
Trazodone21$219$10
Lovastatin16$214$13
Metoprolol17$192$11
Furosemide16$144$9
Allopurinol19$138$7
Triamcinolone Acetonide19$134$7
Atenolol27$131$5
Zolpidem28$120$4
Finasteride11$112$10
Doxepin11$88$8

Money from drug and device companies

$190 in 2025

Industry payments by year
202523None$190
202411None$129
202011$520$520

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Idorsia Pharmaceuticals USTryvio$122
2 payments
  • Meals for Tryvio · 2025-08-08 · $27
  • Meals for Tryvio · 2025-07-22 · $95
Esperion TherapeuticsNexletol$68
1 payment
  • Meals for Nexletol · 2025-08-01 · $68
See all 3 published payments
Every published payment
Idorsia Pharmaceuticals USMeals · 2025-08-08Tryvio$27
Esperion TherapeuticsMeals · 2025-08-01Nexletol$68
Idorsia Pharmaceuticals USMeals · 2025-07-22Tryvio$95
See earlier years (2024, 2020)

2024: $129

Payments by company in 2024
MedtronicSymplicity G3$129
1 payment
  • Meals for Symplicity G3 · 2024-09-26 · $129

2020: $520

Payments by company in 2020
Bayer HealthCare PharmaceuticalsNon-Covered$520
1 payment
  • Consulting for Non-Covered · 2020-02-14 · $520

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Cleerly, Inc. · Transform · 2025Their institution$21,831

Professional record

NPI
1083717359
Licence
CA A65925California A65925: Current · expires 2027-11-30
Trained
University of Texas Southwestern Medical School at Dallas, 1995
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-09-05
NPI last updated
2024-04-24
NPI record certified
2024-04-24

This is when the NPI record was last certified, not a medical board exam.